NAL norwood abbey limited

technology, page-3

  1. 53 Posts.
    Gents, the value here is nothing to do with the cost of the (non)needle - when you get an injection, the vast majority of the revenue goes to the pharma company.

    Pharma have many "elective" drugs stuck in their pipelines because the compounds can't be delivered in pills.

    While I really hate needles, I'm still going to get my measles injections.

    But nobody's going to inject me for my hair loss, obesity, well, even for flu for that matter.

    This company is trying to solve the big pharma's problem of lost opportunities. How much is that worth?

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.